High glucose (30 mM) and high insulin (1 nM), pathogenic factors of type 2 diabetes, increased mRNA expression and synthesis of laminin 1 and fibronectin after 24 h of incubation in kidney proximal tubular epithelial (MCT) cells. We tested the hypothesis that inactivation of glycogen synthase kinase 3 (GSK3) by high glucose and high insulin induces increase in synthesis of laminin 1 via activation of eIF2B⑀. Both high glucose and high insulin induced Ser-9 phosphorylation and inactivation of GSK3 at 2 h that lasted for up to 48 h. This was associated with dephosphorylation of eIF2B⑀ and eEF2, and increase in phosphorylation of 4E-BP1 and eIF4E. Expression of the kinase-dead mutant of GSK3 or constitutively active kinase led to increased and diminished laminin 1 synthesis, respectively. Incubation with selective kinase inhibitors showed that high glucose-and high insulin-induced laminin 1 synthesis and phosphorylation of GSK3 were dependent on PI 3-kinase, Erk, and mTOR. High glucose and high insulin augmented activation of Akt, Erk, and p70S6 kinase. Dominant negative Akt, but not dominant negative p70S6 kinase, inhibited GSK3 phosphorylation induced by high glucose and high insulin, suggesting Akt but not p70S6 kinase was upstream of GSK3. Status of GSK3 was examined in vivo in renal cortex of db/db mice with type 2 diabetes at 2 weeks and 2 months of diabetes. Diabetic mice showed increased phosphorylation of renal cortical GSK3 and decreased phosphorylation of eIF2B⑀, which correlated with renal hypertrophy at 2 weeks, and increased laminin 1 and fibronectin protein content at 2 months. GSK3 and eIF2B⑀ play a role in augmented protein synthesis associated with high glucose-and high insulin-stimulated hypertrophy and matrix accumulation in renal disease in type 2 diabetes.Glycogen synthase kinase 3 (GSK3) 3 was originally identified as an enzyme required for the regulation of glycogen metabolism (1). However, it has been found to be involved in a variety of cellular responses including cytoskeletal regulation (2), cell cycle progression (3, 4), apoptosis (5, 6), and cell adhesion (7). GSK3 regulation of protein synthesis has not been completely understood. GSK3 acts as a switch that regulates both transcription and mRNA translation by controlling the activity of transcription factors and eukaryotic translation initiation factor 2B⑀ (eIF2B⑀), respectively. In the resting cell, GSK3 is unphosphorylated and active, inhibiting the activity of its substrates, e.g. eIF2B⑀ and glycogen synthase. Upon stimulation, GSK3 is phosphorylated on Ser-9 and inactivated, leading to release of inhibition on activity of its substrates. Several kinases are implicated in Ser-9 phosphorylation of GSK3 including p70S6 kinase (8), p90RSK (9), PKC, PKA (10 -12), and Akt (13,14).Augmented protein synthesis contributes to two cardinal manifestations of diabetic kidney disease, i.e. renal hypertrophy and accumulation of extracellular matrix proteins (15). However, the role of GSK3 in these events has not been inves...